APA (7th ed.) Citation

C, B., P, B., R, M., M, B., A, F., M, N., . . . P, M. (2024). A real-life study of daratumumab combinations in newly diagnosed patients with light chain (AL) amyloidosis. Hematological oncology, 42(4), e3289. https://doi.org/10.1002/hon.3289

Chicago Style (17th ed.) Citation

C, Bellofiore, et al. "A Real-life Study of Daratumumab Combinations in Newly Diagnosed Patients with Light Chain (AL) Amyloidosis." Hematological Oncology 42, no. 4 (2024): e3289. https://doi.org/10.1002/hon.3289.

MLA (9th ed.) Citation

C, Bellofiore, et al. "A Real-life Study of Daratumumab Combinations in Newly Diagnosed Patients with Light Chain (AL) Amyloidosis." Hematological Oncology, vol. 42, no. 4, 2024, p. e3289, https://doi.org/10.1002/hon.3289.